COPART vs PEN
COPART (COPART) versus Penumbra Inc (PEN) — a side-by-side from cached financials, not a winner call.
COPART (COPART) common stock.
Penumbra Inc (PEN) is a medical devices company listed on US.
COPART does not have a complete income-statement cache yet.
Latest reported PEN revenue for 2026-06-30 was $764.8M. Net income was $67.4M. PEN currently screens at market cap $9.93B and trailing P/E 237.4.
PEN currently screens at market cap $9.93B and trailing P/E 237.4.
Not investment advice. Open the COPART and PEN stock pages for the full models.
Not investment advice.